NAXREDI
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Jan 2024)
What this means for you
This application is over — abandoned 08 Jan 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88752697
- Mark type
- Stylized text
- Filed
- 09 Jan 2020
- Published for opposition
- 13 Oct 2020
- Abandoned
- 08 Jan 2024
- Attorney of record
- Gene K. Park
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Pharmaceutical preparations, namely, narcotic antagonists; Pharmaceutical preparations, namely, opioid antagonists; Syringes sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Syringes sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Syringes sold filled with narcotic antagonists; Syringes sold filled with opioid antagonists; Injectors sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Injectors sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Injectors sold filled with narcotic antagonists; Injectors sold filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose and addiction; Injectable pharmaceuticals for use in the treatment of substance abuse disorders, addiction, and overdose; Injectable pharmaceuticals, namely, narcotic antagonists; Injectable pharmaceuticals, namely, opioid antagonists
- Class 010 — Medical apparatus: Syringes for pharmaceutical preparations; Injectors for pharmaceutical preparations; Syringes for medical purposes
Owner
- ANTARES PHARMA, INC., EWING, NJ, US
- Pfizer Inc., New York, NY, US
- Pfizer Inc., New York, NY, US
Prosecution history
- 08 Jan 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Jan 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 07 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Jun 2023 — SOU EXTENSION 5 GRANTED
- 02 Jun 2023 — SOU EXTENSION 5 FILED
- 02 Jun 2023 — SOU TEAS EXTENSION RECEIVED
- 22 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Apr 2023 — SOU EXTENSION 4 GRANTED
- 08 Dec 2022 — SOU EXTENSION 4 FILED
- 20 Apr 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Mar 2023 — NOTICE OF REVIVAL - E-MAILED
- 01 Mar 2023 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 01 Mar 2023 — PETITION TO REVIVE-GRANTED
- 01 Mar 2023 — TEAS PETITION TO REVIVE RECEIVED
- 01 Mar 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED